Stocks · News reference
BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion to $15.100 billion-$15.425 billion vs $15.064 billion estimate.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
As September historically brings market volatility, investors should focus on highly profitable companies with strong net income ratios and earnings growth. Three standout stocks meeting rigorous profitability criteria are NVIDIA (63.7% net margin, 93.3% earnings growth), BrightSpring Health Services (2.6% net margin, 82% earnings growth), and Comfort Systems USA (12.8% net margin, 60.7% earnings growth).
Teladoc Health (TDOC) is positioned for growth through chronic care expansion, international presence, and its upcoming Teladoc One platform, with the stock trading at a valuation discount. However, the company faces headwinds from declining BetterHelp revenues, intense virtual care competition, and persistent unprofitability with a $16.5 billion accumulated deficit.
The Benzinga Stock Whisper Index highlights five unique stocks each week that attract high reader and investor interest.
BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $90 price target.